Study of Cyclosporine in Post-LASIK Patients

Completed · Phase 2 · Has a placebo group

Conditions studied: Laser In Situ Keratomileusis

In brief

This study will evaluate the safety and efficacy of Cyclosporine 0.005% and 0.010% eye drops administered twice daily before and following LASIK surgery.

Key facts

Study ID

NCT00991458

Run by

Allergan

People needed

621

Starts

2009-10-01

Expected to finish

2011-04-01

Last updated by the study team

2013-07-11

Who can join

Age: 21 and older, up to 50. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patient is scheduled for bilateral LASIK surgery
• Patient is in good general health
• Eye glasses prescription of -1 to -8

You may not qualify if…

• Significant Dry Eye
• Presence of eye disease
• Uncontrolled systemic disease
• Previous use of RESTASIS®

Where it is running

• Study site — Overland Park, Kansas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.